Participants 53 109 6
type 2 diabetes inadequately controlled on basal insulin
Participants 297 549 9
Patients inadequately controlled [glycated haemoglobin (HbA1c) >7 to â‰¤10% (>53 to â‰¤86â€‰mmol/mol)] on basal insulin (glargine, detemir, NPH) were randomized to empagliflozin 10â€‰mg (nâ€‰=â€‰169), empagliflozin 25â€‰mg (nâ€‰=â€‰155) or placebo (nâ€
